dexloxiglumide has been researched along with Constipation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caballero, N; Serra, J | 1 |
| Burton, D; Camilleri, M; Zinsmeister, AR | 1 |
| Burton, D; Camilleri, CE; Camilleri, M; Carlson, P; Cremonini, F; McKinzie, S; Thomforde, G; Urrutia, R; Zinsmeister, AR | 1 |
2 review(s) available for dexloxiglumide and Constipation
| Article | Year |
|---|---|
Dexloxiglumide for the treatment of constipation predominant irritable bowel syndrome.
Topics: Constipation; Gastric Emptying; Gastrointestinal Motility; Humans; Irritable Bowel Syndrome; Pentanoic Acids | 2016 |
Pharmacodynamic and clinical endpoints for functional colonic disorders: statistical considerations.
Topics: Adult; Benzamides; Bridged Bicyclo Compounds, Heterocyclic; Chenodeoxycholic Acid; Clinical Trials, Phase II as Topic; Colonic Diseases; Constipation; Controlled Clinical Trials as Topic; Cross-Over Studies; Diarrhea; Female; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Male; Middle Aged; Pentanoic Acids; Peptides; Radionuclide Imaging; Serotonin Antagonists | 2013 |
1 trial(s) available for dexloxiglumide and Constipation
| Article | Year |
|---|---|
Effect of CCK-1 antagonist, dexloxiglumide, in female patients with irritable bowel syndrome: a pharmacodynamic and pharmacogenomic study.
Topics: Adult; Constipation; Double-Blind Method; Female; Gastric Emptying; Gastrointestinal Transit; Humans; Irritable Bowel Syndrome; Patient Compliance; Pentanoic Acids; Polymorphism, Genetic; Receptors, Cholecystokinin | 2005 |